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The severe acute respiratory syndrome coronavirus accessory protein ORF6 antagonizes interferon signaling by blocking
karyopherin-mediated nuclear import processes. Viral nuclear import antagonists, expressed by several highly pathogenic RNA
viruses, likely mediate pleiotropic effects on host gene expression, presumably interfering with transcription factors, cytokines,
hormones, and/or signaling cascades that occur in response to infection. By bioinformatic and systems biology approaches, we
evaluated the impact of nuclear import antagonism on host expression networks by using human lung epithelial cells infected
with either wild-type virus or a mutant that does not express ORF6 protein. Microarray analysis revealed significant changes in
differential gene expression, with approximately twice as many upregulated genes in the mutant virus samples by 48 h postinfec-
tion, despite identical viral titers. Our data demonstrated that ORF6 protein expression attenuates the activity of numerous
karyopherin-dependent host transcription factors (VDR, CREB1, SMAD4, p53, EpasI, and Oct3/4) that are critical for establish-
ing antiviral responses and regulating key host responses during virus infection. Results were confirmed by proteomic and chro-
matin immunoprecipitation assay analyses and in parallel microarray studies using infected primary human airway epithelial
cell cultures. The data strongly support the hypothesis that viral antagonists of nuclear import actively manipulate host re-
sponses in specific hierarchical patterns, contributing to the viral pathogenic potential in vivo. Importantly, these studies and
modeling approaches not only provide templates for evaluating virus antagonism of nuclear import processes but also can reveal
candidate cellular genes and pathways that may significantly influence disease outcomes following severe acute respiratory syn-
drome coronavirus infection in vivo.
Novel research strategies are needed to elucidate the complexvirus-host interaction networks that regulate viral pathogen-
esis and to provide rapid response strategies for control of newly
emerging viral pathogens. Prior to 2003, human coronaviruses
were categorized as mildly virulent upper respiratory pathogens;
however, severe acute respiratory syndrome coronavirus (SARS-
CoV) infection results in high mortality rates (10%) (1, 2).
SARS-CoV emerged suddenly from zoonotic reservoirs and rap-
idly circumnavigated the globe in 2003 (3–8). The SARS-CoV pos-
itive-stranded RNA genome encodes a variety of novel genes that
do not exist in other human coronaviruses, which likely contrib-
utes to the alteration of virulence and disease severity (9). In our
study, a systems biological approach was used to examine the con-
sequences of antagonizing karyopherin-dependent nuclear im-
portation during SARS-CoV infection.
Signal-mediated macromolecular transport between the cyto-
plasm and nucleus is an integral part of cellular processes, includ-
ing gene expression, signal transduction, development of antiviral
states, and cell cycle progression. Highly pathogenic RNA viruses,
including SARS-CoV, enteroviruses, Ebola virus, human immu-
nodeficiency virus, cardioviruses, and Nipah viruses, encode pro-
teins that antagonize nuclear importation processes, suggesting a
common modality for regulating viral pathogenesis and disease
outcomes across disparate virus families (10–14). Interestingly,
the consequences of viral antagonism on host nuclear import and
mRNA expression have not been carefully evaluated using
genomic-based strategies. Rather, elegant reductionist approaches
have demonstrated targeted antagonism of innate immune signal-
ing pathways, typically involving interferon (IFN) regulatory fac-
tor 7 (IRF-7) and STAT transcription factors (15–20). Reflecting
this approach, the interferon antagonist activity of the SARS-CoV
ORF6 protein has been demonstrated to mediate its function
by binding to the nuclear importation chaperone protein
karyopherin. ORF6 protein binds specifically to karyopherin 2,
trapping the import factor on intracellular membranes, where the
complex then sequesters karyopherin 1 (17), preventing nuclear
transportation of cargo into the host cell nucleus (see Fig. 1A). As
karyopherin 1 is essential for all nuclear import by karyopherin
 proteins, depletion of this factor may dramatically reduce or
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alter the transport of other cargo by karyopherin-based transport
mechanisms (21). We hypothesized that the ORF6 protein may
actively manipulate the translocation of multiple transcription
factors, coordinately modulating the levels of host transcription
during infection.
Using SARS-CoV as a model system, we investigated whether
the ORF6 accessory protein mediated a specific or more general
block of karyopherin-mediated nuclear translocation and host
gene expression. We identified a cluster of genes that are uniquely
upregulated during infection with a mutant SARS-CoV strain that
does not express ORF6 protein. Our data showed that ORF6
protein expression effectively ablates the activity of numerous
karyopherin-dependent host transcription factors that are critical
for establishing antiviral responses and regulating other key host
responses during virus infection. The transcription factors identi-
fied in these studies (vitamin D receptor [VDR], cyclic AMP re-
ceptor binding protein 1 [CREB1], Oct3/4, hypoxia-inducible fac-
tor 2 [HIF2]-Epas, p53, and SMAD4) play important roles in
the regulation of a variety of cellular processes, including trans-
forming growth factor beta induction, maintenance of normal
lung cell functions, prevention of lung disease phenotypes, and
proper immune cell functions (21–29). Finally, we verified our
hypothesis that the upregulation of nuclear translocation attenu-
ates viral pathogenesis with both in vitro and in vivo studies. To-
gether, these data suggest that the ORF6 protein mediates the
establishment of an intracellular environment that enhances
SARS-CoV replication later in infection by suppressing host
antiviral and innate immune expression cascades. In addition,
these studies suggest that other viral nuclear import antagonists
will also mediate pleiotropic alterations in host gene expression
during infection, potentially leading to broad-based strategies for
intervention and control of viral pathogenesis in vivo.
MATERIALS AND METHODS
Data dissemination. Raw microarray data have been deposited in the
National Center for Biotechnology Information (NCBI) Gene Expression
Omnibus database (30) and are accessible through the GEO series under
accession number GSE33267 (http://www.ncbi.nlm.nih.gov/geo/query
/acc.cgi?acc  GSE33267). Raw proteomics data corresponding to pep-
tide identifications used to populate the AMT tag database are available at
the PRoteomics IDEntification (PRIDE) database (http://www.ebi.ac.uk
/pride/) under the project name “A Systems Biology Approach to Emerg-
ing Respiratory Viral Diseases” in the PRIDE Public Projects folder and
corresponding to PRIDE accession numbers 19877 to 19890. The raw
quantitative proteomics data can be accessed at the Pacific Northwest
National Laboratory (PNNL) Biological Mass Spectrometry (MS) Data
and Software Distribution Center (http://omics.pnl.gov/) in the Systems
Virology Contract Data folder within the Browse Available Data folder.
All data sets and associated metadata have been submitted to the Virus
Pathogen Resource (ViPR; http://www.viprbrc.org). Additional details
from this study and similar studies can be accessed through the Systems
Virology website (http://www.systemsvirology.org).
Cells and viruses. Infections for microarray and proteomics analyses
and validation studies were performed in a clonal population of Calu3
cells (human lung adenocarcinoma cells) sorted for high levels of expres-
sion of the SARS-CoV cellular receptor angiotensin-converting enzyme 2
(ACE2), referred to as Calu3 2B4 cells (31). Calu3 2B4 cells were grown in
minimal essential media (MEM; Invitrogen-Gibco) containing 20% fetal
bovine serum (HyClone) and 1% antibiotic-antimycotic mixture (Invit-
rogen-Gibco). Viral titration assays were performed in Vero E6 cells. Vero
E6 cells were maintained in MEM (Invitrogen-Gibco) containing 10%
fetal clone II (HyClone) and 1% antibiotic-antimycotic (Invitrogen-
Gibco).
Human tracheobronchial epithelial cells were obtained from airway
specimens resected from patients undergoing surgery under University of
North Carolina Institutional Review Board-approved protocols by the
Cystic Fibrosis Center Tissue Culture Core. Primary cells were expanded
to generate passage 1 cells, and passage 2 cells were plated at a density of
2.5 105 cells per well on permeable Transwell-COL (12-mm-diameter)
supports. Human airway epithelium (HAE) cultures were generated by
provision of an air-liquid interface for 6 to 8 weeks to form well-differen-
tiated, polarized cultures that resembled in vivo pseudostratified muco-
ciliary epithelium (32).
Wild-type infectious clone-derived SARS-CoV (icSARS-CoV) and ic-
SARS-CoV ORF6 and their corresponding MA15 mouse-adapted vari-
ants were derived from the Baric laboratory’s infectious clone constructs
as previously described (see Section S1 and Fig. S1 in the supplemental
material) (9, 33, 34). Briefly, genome fragments were amplified in Esche-
richia coli, excised from plasmids by restriction digestion, ligated, and
purified prior to in vitro transcription reactions to synthesize full-length
genomic RNA, which was transfected into Vero E6 cells. The media from
transfected cells were harvested and served as seed stocks for subsequent
experiments. Viral genomes were confirmed by sequence analyses prior to
use in any experiments. All work was performed in a biosafety level 3
facility supported by redundant fans.
Real-time PCR quantification of viral genomic and subgenomic
RNA species. Relative quantities of viral genomic or subgenomic mRNA
were determined by quantitative real-time PCR (qRT-PCR). First-strand
cDNA synthesis was performed using 500 ng of total RNA and Thermo-
Script reverse transcriptase (Invitrogen) according to the manufacturer’s
protocol. The qPCR assay was performed using a SYBR green kit (Applied
Biosystems, Carlsbad, CA) with specific primers for the different RNA
species, according to the manufacturer’s standard protocol. Relative RNA
quantities were determined using the comparative threshold cycle (CT)
method, with human RPL14R2 serving as the endogenous reference and
mock-infected samples serving as the calibrators. Primer sequences are
available upon request.
icSARS-CoV and icSARS-CoV ORF6 infection of Calu3 2B4 cells
and processing for microarray and proteomic analysis. To determine
the pattern of differential gene expression or protein expression for ic-
SARS-CoV-infected, icSARS-CoV ORF6-infected, and mock-infected
cells, Calu3 2B4 cells were plated in triplicate under each condition at each
time point, washed prior to infection, infected at a multiplicity of infec-
tion of 5 (MOI 5), and incubated at 37°C for 40 min. The inoculum was
removed, cells were washed 3 times with 1 phosphate-buffered saline
(PBS), and then fresh medium was added prior to time zero. For both
microarray and proteomic analyses, at 0, 3, 7, 12, 24, 30, 36, 48, 54, 60, and
72 h postinfection, medium was collected to determine viral titers at each
time point for each well and cells were either washed in 1 PBS and then
harvested in TRIzol (Invitrogen) and stored at 80°C (for RNA) or
washed 3 times in cold 150 mM ammonium bicarbonate buffer, lysed for
15 min in 8 M urea, and stored at80°C (for protein).
Infection of primary HAE cell cultures. Infection of HAE cultures
with icSARS-CoV and icSARS-CoV ORF6 was performed as previously
described by our group (35–37). Briefly, triplicate cultures were washed
with 1PBS, and 200l of mock, icSARS-CoV, and icSARS-CoVORF6
inocula was added to the apical surface. Cultures were incubated at 37°C
for 2 h; the inoculum was removed, and unbound viruses were removed
by washing three times with 1 PBS. Apical wash samples were harvested
to analyze viral growth kinetics at 2, 24, 48, and 72 h postinfection and
were assayed by plaque assay in Vero E6 cells (36).
RNA isolation, microarray processing, and identification of differ-
entially expressed transcripts. RNA isolation from Calu3 2B4 cells and
the subsequent microarray processing and identification of differentially
expressed transcripts were performed as described previously (38). All
probes were required to pass Agilent quality control (QC) flags for all
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replicates of at least one infection time point (33,631 probes passed).
Differential expression was determined by comparing icSARS-CoV- and
icSARS-CoV ORF6-infected replicates to mock-infected replicates for
each time point, based on a linear model fit for each transcript. Criteria for
differential expression were an absolute log2-fold change of 1.5 and a false
discovery rate (FDR)-adjusted P value of 	0.05 for a given time point.
Differential expression was also calculated directly between icSARS-CoV
and icSARS-CoV ORF6 for each time point by using the criteria of a
2-fold change and an FDR-adjusted P value of 	0.05. Significant tran-
script values were transformed for clustering and network analysis to the
fold change (log2) of icSARS-CoV- or icSARS-CoVORF6-infected sam-
ples compared to time-matched mock-infected samples.
To process primary HAE samples, both the apical and basolateral sur-
faces of the cultures were washed 3 times in 1 PBS and stored at80°C
in RNAlater (Ambion/Invitrogen). To isolate total RNA, each membrane
was washed twice with 500 l of 4 M guanidinium thiocynate, 25 mM
sodium citrate, 0.5% Sarkosyl, 0.1 M 2-mercaptoethanol. The washes
were combined and, following shearing of the DNA, total RNA was iso-
lated through phenol-chloroform extraction. The RNA was further puri-
fied using Qiagen RNeasy minicolumns per the manufacturer’s instruc-
tions (38). Equivalent amounts of RNA from three biological replicates
from each condition were pooled. Microarray analysis was performed as
previously described (39) using Agilent 4x44K whole human gene expres-
sion microarrays.
Functional enrichment and transcription factor analysis. Func-
tional enrichment statistics and network analysis were determined using
DAVID (40, 41) and Metacore (GeneGo, St. Joseph, MI) to identify the
most significant processes affected by infection. The DAVID functional
annotation tool utilizes the Fisher exact test to measure gene enrichment
in Gene Ontology (GO) biological process category terms for significant
genes compared to background, which included all genes on the Agilent
platform that passed the QC criteria. To identify major transcriptional
regulators whose nuclear import is controlled by karyopherins, the statis-
tical Interactome tool in MetaCore was used to measure the interconnect-
edness of genes in the experimental data set relative to all known interac-
tions in the background data set. Statistical significance of overconnected
interactions was calculated using a hypergeometric distribution, where
the P value represented the probability of a particular mapping arising by
chance for experimental data compared to the background (42). In order
to determine the consequence of removal of the nuclear import block in
SARS-ORF6 infection, significantly overconnected transcription factors
were filtered for those whose transport is regulated by karyopherins in the
cell. Networks were constructed in MetaCore for experimental data by
using an algorithm that identified the shortest path to directly connect
nodes in the data set to transcription factors. Network visualizations were
created in MetaCore or Cytoscape (43).
Proteomic processing and analysis. The detailed proteomic method-
ology, including sample preparation, processing, and analysis methods,
are provided in Section S2 of the supplemental material. Cell lysates were
trypsin digested and fractionated by strong cation exchange as previously
described (44, 45). A novel accurate mass and time (AMT) tag database
(46) for virus-infected Calu3 2B4 cells was generated by liquid chroma-
tography-tandem mass spectrometry (LC-MS/MS) analysis (44, 47), us-
ing combined aliquots of the icSARS-CoV-, icSARS-CoV ORF6-, and
mock-infected samples. Following AMT tag database generation, LC-MS
analyses were performed on all icSARS-CoV-, icSARS-CoVORF6-, and
mock-infected samples to generate quantitative data, using identical
chromatographic and electrospray conditions as for LC-MS/MS analyses.
The LC system was interfaced to an Exactive mass spectrometer (Thermo-
Scientific), and the temperature of the heated capillary and the electros-
pray ionization voltage were 250°C and 2.2 kV, respectively. Data were
collected over the mass range 400 to 2,000 m/z. Quantitative LC-MS data
sets were processed using the PRISM data analysis system (48), which is a
series of software tools developed in-house (e.g., Decon2LS [49] and
VIPER [50], which is freely available at http://ncrr.pnl.gov/software/).
Individual steps in this data processing approach are reviewed in reference
46. The peak intensity values (i.e., abundances) for the final peptide iden-
tifications were processed in a series of steps using MatLab R2010b, in-
cluding quality control (51, 52), normalization (53), and quantification to
protein level (54). Comparative statistical analyses of time-matched
mock-infected with icSARS-CoV- and icSARS-CoV ORF6-infected
samples was performed using a Dunnett adjusted t test to assess differ-
ences in protein average abundance, and a G-test was used to assess asso-
ciations among factors due to the presence/absence of a response (51).
ChIP and real-time PCR. Chromatin immunoprecipitation (ChIP)
analysis was performed by using the ChIP assay kit (Millipore). Briefly,
Calu3 2B4 cells were infected with icSARS-CoV or icSARS-CoV ORF6
or mock infected, as described above, and harvested at 0, 24, and 48 h
postinfection. Sonication conditions were chosen to produce the desired
size distribution of chromatin, between 200 and 1,000 bp. Samples were
then immunoprecipitated with anti-CREB antibody (clone aa5-24; Milli-
pore), anti-VDR antibody (clone ab3508; Abcam), or an anti-mouse IgG
(Jackson Laboratory) as a control. To verify the presence of a particular
promoter fragment following ChIP, qRT-PCR was performed. Response-
specific promoter regions of MMP19, CDKN1A, and MCL-1 (identified
as target genes downstream of CREB or VDR) were chosen and amplified
by using the following primers: MMP19_f, TCT CCC ACC AAT ACC
AGC AGT TCA; MMP19_r, GGA TAC TCG GGA GGG TGG ACG TAG;
CDKN_f, TCT TGG ATT GAG GAA CAG GCA ATG; CDKN_r, TCC
CAA CAA ACA AGG GGT GGT T; MCL1_f, AGC CTG TTT GGT GGT
GTC TTC ACA; MCL1_r, GAG ATG GGG TTT TCA CGA TGT TGG. To
determine the levels (relative fold enrichment) of immunoprecipitated
chromatin (specific promoter region), the CT values were analyzed by the
standard curve method, and each sample was normalized to the appro-
priate IgG sample and to the corresponding time-matched mock sample
(55). Data presented are the means 
 standard errors of means for trip-
licate samples.
Infection of C57BL/6J mice with icSARS-CoV or icSARS-CoV
ORF6.Female C57BL/6J mice (B6; 20-week-old mice from Jackson Lab-
oratories) were anesthetized with a ketamine (1.3 mg/mouse)–xylazine
(0.38 mg/mouse) mixture administered intraperitoneally in a 50-l vol-
ume. Each mouse was intranasally inoculated with 105 PFU wild-type
icSARS-CoV mouse-adapted virus or icSARS-CoV ORF6 mouse-
adapted backbone diluted in PBS in a volume of 50l. Mice were weighed
daily, and at 1, 2, 4, and 7 days postinfection, 5 animals from each infec-
tion group were euthanized and the lungs were removed to determine
viral titers. The large, lower lobe of the right lung was homogenized in 1 ml
of sterile PBS with glass beads by using a Magnalyser (Roche) at 6,000 rpm
for 60 s. Aliquots of 200 l of lung homogenate were plated on Vero E6
cells in serial 10-fold dilutions to determine virus titers. All mice were
housed using individually ventilated Sealsafe cages and the SlimLine sys-
tem (Tecniplast, Exton, PA) under biosafety level 3 conditions. Experi-
mental protocols were reviewed and approved by the Institutional Animal
Care and Use Committee of the University of North Carolina, Chapel
Hill.
RESULTS
icSARS-CoV and icSARS-CoV ORF6 growth kinetics in hu-
man lung cells. To determine if deletion of the SARS-CoV ORF6
gene caused a specific or more general effect on host transcription
following the release of the block on karyopherin-mediated nu-
clear import, Calu3 2B4 cells were infected with icSARS-CoV or
icSARS-CoVORF6 at a high MOI (MOI of 5) to minimize para-
crine signaling effects in uninfected cells. Medium, total RNA, and
protein were harvested at 0, 3, 7, 12, 24, 36, 48, 54, 60, and 72 h
postinfection. Serial dilutions of the medium samples were gener-
ated to determine viral titers, and the results for six replicate in-
fections, graphed as the PFU per ml, are shown in Fig. 1B. For both
icSARS-CoV and icSARS-CoV ORF6, viral titers increased by 4
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FIG 1 ORF6 function and replication kinetics in Calu3 2B4 cells. (A) Function of the interferon antagonist ORF6 protein in SARS-CoV infection. The diagram
is a schematic representation of the block of nuclear translocation of the karyopherins induced by the SARS-CoV interferon antagonist, ORF6 protein. The ORF6
protein sequesters karyopherin 2 and 1 on the cytoplasmic face of the endoplasmic reticulum in infected cells, preventing nuclear translocation of many
factors, including transcription factors (TF) that require karyopherins for nuclear entry, preventing transcription of downstream genes. K2, karyopherin 2;
K1, karyopherin 1; ER, endoplasmic reticulum. (B and C) Triplicate wells of Calu3 2B4 human lung cells were infected with either icSARS-CoV or
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logs by 30 h postinfection, with peak titers reaching108 at 36 h
postinfection (Fig. 1B). No significant difference in titer between
icSARS-CoV and icSARS-CoV ORF6 was detected at any time
postinfection, and a similar percentage of cells was infected (data
not shown). At the high MOI, icSARS-CoV and icSARS-CoV
ORF6 genome and subgenomic RNA transcript levels were de-
tected by 6 h postinfection and remained at nearly identical levels
at early and late times postinfection (Fig. 1C). In wild-type- but
not icSARS-CoV ORF6-infected cells, ORF6 protein expression
was detected after 24 h and increased through 48 to 54 h postin-
fection (Fig. 1D). Under identical conditions, membrane glyco-
protein expression was detected at 24 h and peaked between 54
and 60 h during both virus infections (Fig. 1E). These results ex-
tend previous studies that demonstrated that the SARS-CoV ac-
cessory ORF6 interferon antagonist is dispensable at an MOI of
1 (9, 17).
Gene expression analysis in icSARS-CoV- and icSARS-CoV
ORF6-infected human lung cells.To determine the effect of the
removal of ORF6 protein on mRNA synthesis levels and species in
SARS-CoV-infected Calu3 2B4 cells, total RNA was harvested in
triplicate at the time points described above, and global mRNA
expression was analyzed. Little host gene differential expression
was detected during the first 24 h of icSARS-CoV or icSARS-
CoVORF6 infection (Fig. 2A to C), supporting previous studies
that indicated that coronaviruses enter the host cell “quietly,” per-
haps by sequestering double-stranded RNA away from or thwart-
ing recognition by the host cell sensing machinery early after in-
fection (56, 57). Overall, a total of 6,947 genes were differentially
expressed (P 	 0.05; 2-fold change) when icSARS-CoV ORF6
and icSARS-CoV samples were directly compared across each
time point. Figure 2A shows patterns of gene expression after hi-
erarchical clustering with expression values. Most genes were
more highly up- or downregulated in icSARS-CoV ORF6-in-
fected than in icSARS-CoV-infected cells compared to the mock-
infected samples, such that the primary difference between infec-
tions was the magnitude of response. This response differential
between the two viruses was also apparent when we compared the
total number of differentially expressed genes over time for each
virus (Fig. 2B). Differential gene expression changes peaked be-
tween 48 and 72 h postinfection for both icSARS-CoV and ic-
SARS-CoV ORF6. During this time period, significantly more
differentially expressed genes were transcribed in icSARS-CoV
ORF6-infected Calu3 2B4 cells than in icSARS-CoV-infected
cells (P 	 0.0001, chi-square test), likely due to one of the func-
tions described for the ORF6 protein as a transcriptional block,
mediated by the prevention of karyopherin nuclear translocation
(Fig. 1A and 2B). After 48 h, there was 50 to 80% overlap in
differentially expressed genes between time points, suggesting that
the pool of differentially expressed genes is relatively consistent
later in the time course of infection (Fig. 2C). This pattern of
expression, which is also reflected in Fig. 2A, is likely a conse-
quence of the differences in upstream gene regulation between
icSARS-CoV ORF6 and icSARS-CoV and indicates that early
transcriptional regulation by the ORF6 protein results in dramatic
changes in host gene expression that are maintained throughout
the 72-h time course.
In addition, we noted a trend for delay in the host response to
icSARS-CoV ORF6 infection, such that icSARS-CoV had more
differentially expressed genes early in the time course between 0
and 36 h postinfection (Fig. 2B). Many of the 202 differentially
expressed genes between icSARS-CoV ORF6 and icSARS-CoV
at 0 to 24 h (Fig. 2C) were expressed at similar levels at later time
points, indicating that the host response eventually “catches up”
for icSARS-CoV ORF6. However, some of the most highly dif-
ferentially expressed genes between the viruses were detected as
early as 24 h postinfection, including matrix metalloproteinase 19
(Mmp19), calcitonin  (Calc), and calcitonin beta (Calc). This
early response period included genes enriched for interferon sig-
naling and innate immune response pathways, specifically the Jak-
STAT, Th17, and interleukin-4 signaling pathways, suggesting
that the presence or absence of the ORF6 gene may either mediate
early differences in the kinetics of nuclear import or promote an
early replication-enhancing phenotype (87). As the latter pheno-
type was not evident at a high multiplicity of infection (Fig. 1B and
C), the former possibility may be more likely.
Enrichment of biological processes following infection. Al-
though previous studies have indicated that the ORF6 protein is
an interferon antagonist, it is less clear whether the block in nu-
clear import specifically targets interferon signaling or represents
an outcome associated with a more global block in the import of
nuclear cargo, including transcription factors (17). A summary of
our overall modeling approach with details of the individual steps
is described in Section S3 of the supplemental material and is
outlined in Fig. S2 of the supplemental material. To determine the
significant biological processes associated with icSARS-CoV
ORF6 differential gene expression, the data set was first reduced
to six clusters by K-means based on common patterns of expres-
sion across genes (Fig. 2A), and then significant enrichment (P	
0.05) of biological process Gene Ontology categories was calcu-
lated for each cluster individually (Fig. 2A). Processes related to
icSARS-CoVORF6 (MOI of 5). Medium from each well was collected and analyzed by plaque assay for viral growth kinetics in Vero E6 cells, while the cells were
harvested for either total RNA for transcriptomic or total protein for proteomic analysis. In panel B, data are shown as the average titer obtained at each time point
(6 samples per time point) and were plotted as the PFU/ml. Peak titers for both viruses were detected at 36 h postinfection, and no significant differences in viral
titers were detected at any time point. Error bars are the standard deviations of the replicate wells. In panel C, total RNA from infected samples was analyzed by
real-time PCR to determine the levels of viral mRNA species (genomic RNA, spike subgenomic RNA, and envelope subgenomic RNA) produced over the time
course of infection. No significant differences were detected at any time postinfection at a high MOI in human lung epithelial cells. Symbols in panel B: closed
circles with unbroken line, icSARS-CoV; closed triangles with dashed line, icSARS-CoV ORF6. Color coding for panel C: green bars, icSARS-CoV genomic
RNA; orange, icSARS-CoV spike subgenomic RNA; blue bars, icSARS-CoV envelope subgenomic RNA; white bars, icSARS-CoV ORF6 genomic RNA; black
bars, icSARS-CoV ORF6 spike subgenomic RNA; yellow bars, icSARS-CoV ORF6 envelope subgenomic RNA. (D and E) Comparison of viral structural
protein (M membrane in panel D) and viral accessory protein (ORF6 in panel E) abundance as determined by global proteomics analysis. Values for proteins
represent mean protein abundance levels as measured by mass spectrometry. By 24 h postinfection, M protein was detected for each virus, and the amounts
increased through 54 h postinfection. The ORF6 protein was detectable exclusively in the icSARS-CoV-infected samples and also increased in expression through
54 h postinfection. Error bars represent standard errors of the means based on mean protein abundance values derived from mass spectrometry readings of three
independent samples at each time point. Symbols and abbreviations in panels D and E: blue lines, icSARS-CoV-infected cells; red lines, icSARS-CoV ORF6-
infected cells; black lines, mock-infected cells.
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transcription, nuclear signaling, cell proliferation and death, and
host antiviral and the immune response were upregulated in ic-
SARS-CoV ORF6 compared to icSARS-CoV (clusters C4, C5,
and C6), while cell cycle and select metabolic processes, like DNA
and lipid metabolism, were downregulated (clusters C1, C2, and
C3) (Fig. 2A). These data suggest that the ORF6 protein antago-
nizes nuclear import processes and host transcription.
Transcription factor analysis.Viral antagonists of nuclear im-
port have been well documented (10–14); however, it is not clear
whether these antagonists selectively and/or differentially regulate
nuclear cargo importation, resulting in hierarchical and cell-type-
specific patterns of antagonism of host gene expression. The
SARS-CoV model is particularly appropriate to address this ques-
tion, as the ORF6 protein binds karyopherin 2, suggesting a se-
lective targeting of cargo. However, the process is further compli-
cated by the ORF6 protein-karyopherin 2 complex’s capacity to
also sequester karyopherin 1, which is essential for all nuclear
import via karyopherins (Fig. 1A). The pattern of expression in
gene cluster C4, which included 1,674 genes exclusively upregu-
lated in icSARS-CoVORF6 but unchanged in icSARS-CoV, was
enriched in biological processes for chromosome organization
and regulation of gene expression and nucleosome assembly. This
was particularly interesting, given that one of the ORF6 protein
mechanisms of action is prevention of nuclear translocation of
karyopherin-dependent cellular factors. Therefore, we focused on
the genes in cluster C4 to identify potential downstream targets of
karyopherins whose transcription is blocked in icSARS-CoV in-
fection. In particular, we evaluated whether transcription factors
whose transport is regulated by karyopherins were overconnected
(transcription factors with a significant number of downstream
target genes that were differentially expressed, in this case either
up- or downregulated [P	 0.05]) to downstream gene expression
networks (or to downstream genes whose expression is regulated
by the same transcription factor) by hypergeometric distribution
within the C4 cluster. When the number of connections between
target genes in the data set and upstream regulatory transcription
factors are greater than would be expected by chance (based on the
number of known connections), this indicates that these tran-
scription factors are enriched and are important regulators of the
host response by the ORF6 protein. All of the transcription factor
hubs (schematically represented by large circles in Fig. 3) associ-
ated with gene cluster C4 that were identified as being regulated by
karyopherins in MetaCore are listed in Table 1. Six of these tran-
scription factors (VDR, CREB1, Oct3/4, HIF2/Epas1, p53, and
FIG 2 Differentially expressed (DE) genes in icSARS-CoV-infected versus icSARS-CoV ORF6-infected Calu3 2B4 cells. (A) Heat map and table of gene
ontology categories. The heat map represents unsupervised hierarchical clustering of the 6,947 differentially expressed genes (P	 0.05; 2-fold change) between
icSARS-CoV and icSARS-CoV ORF6 infection of Calu3 2B4 cells, from 0 to 72 h postinfection. Values are the fold change (log2) compared to time-matched
mock infection or icSARS-CoV infection as indicated. Colored bars represent gene tree subclusters. On the right, functional enrichment of significant (P	 0.05)
biological process Gene Ontology categories for gene tree clusters C1 to C6. Genes within each cluster are indicated on the far right of the heat map. (B) Bar graph
of differentially expressed genes (P	 0.05, 1.5-fold change [log2]) for time-matched comparisons in icSARS-CoV versus mock, icSARS-CoV ORF6 versus
mock, or icSARS-CoV ORF6 versus icSARS-CoV at 0 to 72 h postinfection. ***, from 48 to 72 h postinfection, nearly twice the number of genes were
differentially expressed in icSARS-CoVORF6-infected versus icSARS-CoV-infected cells (P	 0.001), indicating the ORF6-dependent nuclear import block has
been released. (C) Circle diagram of differentially expressed genes between icSARS-CoV ORF6 and icSARS-CoV across the time course.
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SMAD4) were significantly (P	 0.05) overconnected to the data
set (Table 1), indicating that there was differential signaling
through these transcription factor hubs when comparing icSARS-
CoVORF6 to icSARS-CoV. Over 350 gene nodes in the C4 clus-
ter directly interact with these six transcription factors (Fig. 3),
based on information in the Metacore knowledge base, suggesting
their transcription is specifically blocked in the presence of func-
tional ORF6 protein. As a summary of our network analysis, we
graphed the fold change over mock for all of the genes regulated by
each of the six transcription factors identified by our modeling
approaches (Fig. 4A). In each graph, the differentially expressed
networks in the icSARS-CoV ORF6-infected cells are signifi-
cantly upregulated (7- to 22-fold increase over mock, which was
significant from 48 to 60 h postinfection for all of the transcription
factors) compared to steady levels in the icSARS-CoV-infected
cells, suggesting that the release of the ORF6 protein-mediated
nuclear importation block does affect cellular transcription and is
not limited to immune-responsive transcription factors. In con-
trast, two transcription factors (beta-catenin and androgen recep-
tor) that do not require karyopherin to translocate to the nucleus
are shown in Fig. 4B and demonstrate similar differential expres-
sion patterns between icSARS-CoV RF6 and wild-type virus
(only a 1.5-fold difference above mock, and the changes were sig-
nificant only at 72 h postinfection for beta-catenin) through 60 h.
The initial targeted approach that identified the six transcrip-
tion factors was restricted to the subset of genes in cluster C4 (Fig.
2A), which were upregulated exclusively in icSARS-ORF6-in-
fected cells. However, we wondered if additional karyopherin-
regulated transcription factors were also present in networks gen-
erated from the original 6,947 genes (in all 6 clusters) identified
FIG 3 Identification of transcription factor hubs directly affected by removal of ORF6-dependent nuclear import block. The schematic shows the network for
significantly overconnected transcription factors (P 	 0.05) whose nuclear transport is prevented by ORF6 in wild-type SARS-CoV infection. White circles
represent overconnected transcriptional hubs; dark gray circles represent target nodes whose relative expression was lower with icSARS-CoV than with
icSARS-ORF6; light gray circles represent karyopherins; gray lines represent edge connections between hubs, nodes, and karyopherins; heavy black lines
represent direct edge connections between karyopherins and transcriptional factor hubs. The enlarged inset includes genes in the VDR and CREB1 networks for
which transcriptional patterns were confirmed by HAE transcriptomic and Calu3 2B4 proteomic data (see Fig. 5 and 6, respectively).
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(Fig. 2A), which would suggest that karyopherins import tran-
scription factors that both positively and negatively regulate
downstream target genes during the course of SARS-CoV infec-
tion. To answer this question, we expanded our transcription fac-
tor analysis to include all significant genes in the data set, resulting
in 27 overconnected transcription factors whose nuclear impor-
tation was mediated by karyopherins (Table 2). This analysis pro-
vided a more global understanding of the potential impact of the
nuclear importation block during SARS-CoV infection compared
to the more targeted approach illustrated in Fig. 3 and 4. For
example, STAT1 was identified as an important karyopherin-me-
diated regulator of gene expression during infection. Our labora-
tory and others have previously observed nuclear translocation of
STAT1 in the absence of the ORF6 protein and the upregulation of
common targets (i.e., cyclooxygenase 1 and 2/prostaglandin G/H
synthase 1 and 2) in icSARS-ORF6-infected but not in wild-
type-infected cells (see Fig. S3A and B in the supplemental mate-
rial) (17, 58). For Calu3 2B4 cells, our data suggest that one of the
functions of the ORF6 protein is to mediate complex hierarchical
antagonism phenotypes of the nuclear import machinery, antag-
onizing different cellular responses during virus infection.
Validation of transcription factor hubs in human primary
airway epithelial cells. To independently confirm the transcrip-
tion factors identified from network-based modeling analysis of
the microarray data with Calu3 2B4 cells, similar modeling ap-
proaches were performed to identify transcription factors from
microarray data for icSARS-CoV- and icSARS-CoV ORF6-in-
fected primary HAE cell cultures. Total RNA was harvested and
analyzed by using an Agilent microarray from wild-type- and ic-
SARS-CoV ORF6-infected HAE cultures at multiple times
postinfection, and the data were compared to Calu3 2B4 tran-
scriptomic data sets to determine if similar targets (genes down-
stream of the transcription factors identified from just the Calu3
2B4 microarray data) could be identified in both primary and
traditional cell isolates. We first examined the viral growth kinet-
ics in HAE cultures and determined that icSARS-CoV titers
peaked at 48 h postinfection (Fig. 5A). In contrast, replication
titers for icSARS-CoVORF6 increased over the entire 72-h time
course (Fig. 5A). At a slightly reduced MOI (Calu3 2B4 cells at an
MOI of 5 versus HAE at an MOI of 2), icSARS-CoVORF6 dem-
onstrated slower growth kinetics until later in infection in primary
cells, consistent with a role in early replication (Fig. 5A) and (59).
Transcription factor analysis of the HAE data set resulted in 7
enriched transcription factor hubs regulated by karyopherins
(P 	 0.05), including RelA, C-jun, CREB1, Hif1, C-fos, VDR,
and SMAD3. Two of the enriched transcription factor hubs in
HAE cultures, CREB1 and VDR, were also identified as important
in the targeted Calu3 2B4 analysis of exclusively upregulated dif-
ferentially expressed genes (cluster C4), whose transcription fac-
tors enter the nucleus in a karyopherin-mediated process (Table 1;
Fig. 3 and 4), while the other 4 transcription factors overlapped
the hubs identified from the global Calu3 2B4 gene microarray
data set (Table 2), independently confirming the overlap of target
genes regulated by the VDR and CREB1 transcription factors be-
tween HAE and Calu3 2B4 cells. A comparison of the CREB1 and
VDR transcription factor networks, which were significantly en-
riched in both HAE and Calu3 2B4 cells, is shown in Fig. 5B (see
also Fig. S4 in the supplemental material) and illustrates the genes
that are either uniquely regulated by the overconnected transcrip-
tion factor gene targets in each cell type or are genes that are
common to both cell types. The mRNA expression levels (from
the microarray data) for representative individual genes that were
differentially expressed in both the HAE and Calu3 2B4 microar-
ray data sets are graphed in Fig. 5C for comparison, including the
genes B cell translocation gene 2 (Btg2), forkhead box 03a
(Foxo3a), hypermethylated in cancer 2 (Hic2), human p-throm-
boglobulin gene (Ptg), thiamine transporter gene (Scl19a2), glu-
cose transporter gene (Scl2a6), transforming growth factor 3
(TGF3), and POK family transcription factor (Zbtb5). Tran-
scription factor analysis in HAE cultures resulted in strong overlap
with the transcription factor hubs identified in Calu3 2B4 cells and
further supported the importance of karyopherin-mediated nu-
clear importation during SARS-CoV infection.
Proteomic and ChIP-PCR validation of transcriptional
hubs. To independently validate our transcriptomic results, we
performed shotgun proteomics using the AMT tag approach and
ChIP-PCR, with parallel sets of Calu3 2B4 cells infected with
icSARS-CoV and icSARS-CoV ORF6. Following proteomic
analysis, a total of 864 proteins were significantly (P 	 0.05) dif-
ferentially expressed between icSARS-CoV- and icSARS-CoV
ORF6-infected Calu3 2B4 cells across all time points. To most
directly determine how the proteomics contributes to our under-
standing of the role(s) for the ORF6 protein in karyopherin-me-
diated nuclear translocation and host gene expression, we first
integrated the transcriptomic and proteomic data sets. From the
integrated data, we obtained a more comprehensive view of the
changes mediated by the ORF6 protein in Calu3 2B4 cells at both
the gene and protein levels, allowing us to determine whether
karyopherin-mediated transcriptional hubs are further enriched
(i.e., more significant) with the addition of the proteomic data.
For example, if the proteomic data support a role for the ORF6
protein in karyopherin-mediated nuclear transport, then we
would expect an increase in the enrichment scores (increased sig-
nificance) of these hubs after addition of the proteomics; other-
wise, the values would decrease. From a biological perspective, the
TABLE 1 Transcription factor hubs associated with gene cluster C4a














a *, the transcription factor is overrepresented in the data set, based on the connectivity
ratio (actual/expected), calculated as the ratio of the actual number of connections to
genes in the C4 cluster (see Fig. 2B) versus the number of connections expected using
the Agilent platform. Bold highlighted transcription factors are significantly (P	 0.05)
overrepresented in the data set.
b Karyopherin  (importin 1).
c Karyopherin 2 (importin 1).
d The “Other KPNA” (karyopherins) category includes karyopherin 1 (importin 5)
and karyopherin 3 (importin 4). EPAS1 (HIF2A) uses importins 1, 3, 5, and 7.
VDR uses importin 4.
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FIG 4 Differential gene expression quantitation for transcription factor networks. Average gene expression for icSARS-ORF6 (dotted lines) and icSARS-CoV
(solid lines) for target gene nodes (mRNA microarray values for genes regulated by transcription factors) are shown. For each network, a group of genes is
regulated by a specific transcription factor. (A) Karyopherin target networks (VDR, CREB1, Oct3/4, p53, EpasI, and SMAD4) from cluster C4 (Fig. 2). (B)
Representative nonkaryopherin target network. Values are the average fold change (log2)
 the standard error compared to time-matched mock infection for 0
to 72 h postinfection. Significant differences in gene expression between icSARS-CoV and icSARS-ORF6 at each time point were calculated by a two-way
analysis of variance with Bonferroni multiple testing correction and are indicated by the following lowercase letters: a, P 	 0.05; b, P 	 0.01; c, P 	 0.0001.
CTNNB1, beta catenin 1; AR, androgen receptor.
SARS-CoV Nuclear Import Block and Host Transcription
April 2013 Volume 87 Number 7 jvi.asm.org 3893
enrichment scores (P values) represent how connected the tran-
scription factors are to downstream targets (genes or proteins) in
the data set compared to the number of targets expected by
chance. If a transcriptional hub is significantly (P 	 0.05) more
connected to the data set, this suggests that signaling through this
hub is uniquely regulated, based on the experimental conditions:
in this case, through deletion of ORF6. We can use the integrated
gene and protein data to identify significant hubs whose down-
stream targets may primarily be detected at the protein level and
whose enrichment scores are greatly elevated by inclusion of the
proteomics data. In our study, transcription factor analysis of the
combined Calu3 2B4 proteomics and transcriptomics data re-
sulted in an increase in enrichment scores, ranging from 1.5 
1012- to 2 1012-fold, for 22 out of 27 of the transcription factor
hubs requiring karyopherin for nuclear importation, including 5
out of the 6 transcription factor hubs uniquely upregulated during
icSARS-CoV ORF6 infection (Table 2). This suggests that many
protein nodes in the proteomic data set share common upstream
transcription factor regulators with gene nodes in the transcrip-
tional data, including those that require karyopherin for nuclear
import. For four transcription factor hubs in particular, C-myc,
Rela, specificity protein 1 (Sp1), and STAT1, values from the com-
bined transcriptomic/proteomic analysis were1,000-fold more
significant than for the transcriptomics alone, demonstrating the
added value of including targets from both data types (Table 2). In
support of the transcription factor analysis, expression levels of
individual downstream targets were confirmed between Calu3
2B4 transcriptional and proteomics analyses. Enhancer of mRNA-
decapping enzyme 3 (EDC3) and Golgi apparatus adapter-related
complex of proteins mu 1 subunit (AP3M1), two target gene
nodes predicted to be a part of CREB1 networks, were measured at
both the transcript and protein levels (Fig. 6). Individual RNA
expression values derived from microarray analysis demonstrated
increased RNA expression trends in icSARS-CoV ORF6 versus
icSARS-CoV in both EDC3 and AP3M1 (Fig. 6A and C). Coordi-
nately, protein abundance also increased at late times during ic-
SARS-CoV ORF6 infection; in contrast, icSARS-CoV infection
protein levels failed to rise above mock infection values (Fig. 6B
and D). When directly compared, both gene and protein analyses
demonstrated augmentation of these gene nodes in icSARS-CoV
ORF6 infection at late times compared to icSARS-CoV infec-
tion. Together, these data confirm increased expression of tar-
geted gene nodes downstream of identified transcriptional factors
in icSARS-CoV ORF6 infection, increases that are absent in ic-
SARS-CoV infection.
Finally, to demonstrate that the transcription factors we iden-
tified were actively engaged in transcription during icSARS-CoV
ORF6 infection, we performed ChIP followed by real-time PCR
(ChIP–RT-PCR) of target gene transcripts. Calu3 2B4 cells were
infected with icSARS-CoV or icSARS-CoV ORF6 or mock in-
fected, protein and DNA were cross-linked, genomic DNA was
sheared, and VDR- and CREB1-bound DNA promoter regions
were precipitated with antisera directed against each of these tran-
scription factors. Next, gene-specific primer pairs were used to
amplify DNA regions of interest by real-time PCR. The results for
transcription factor-specific antisera were compared to control
IgG precipitations and time-matched mock-infected controls. We
chose to amplify three representative downstream target genes:
the matrix metalloproteinase 19 (MMP19) and cyclin-dependent
kinase inhibitor 1A (CDKN1A) CREB1-regulated genes, as well as
the myeloid leukemia cell differentiation gene (Mcl-1), a down-
stream target of VDR. Figure 7 shows the significant increase in
the amount of chromatin precipitated relative to the fold enrich-
ment in icSARS-CoV ORF6-infected samples for MMP19,
CDKN1A, and Mcl-1 at both 24 and 48 h postinfection compared
to wild-type icSARS-CoV. These results confirm that at least two
transcription factors identified by modeling are significantly en-
riched on the promoter elements of their target genes following
icSARS-CoV ORF6 infection, supporting the microarray data
and validating our modeling approaches.
TABLE 2 Significantly enriched transcription factor hubs regulated by








P valuec,gActuald Expectede Ratiof P valueg
p53 450 339.30 1.33 1.92E12 3.74E14*
CREB1 364 265.40 1.37 2.79E12 6.93E13*
VDR 103 74.82 1.38 1.76E04 2.13E05*
Epas1 54 36.94 1.46 1.29E03 3.78E05*
SMAD4 121 91.28 1.33 2.95E04 1.13E04*
Oct-3/4 156 121.20 1.29 2.09E04 2.33E04
C-myc 542 476.90 1.14 1.87E04 8.21E17**
Rela 260 182.30 1.43 6.12E11 9.00E15**
C-jun 287 197.90 1.45 6.32E13 1.59E14*
Sp1 702 595.90 1.18 6.82E08 2.66E14**
Hif1a 177 124.90 1.42 1.22E07 1.46E10*
Ahr 132 88.93 1.48 2.84E07 6.88E09*
Irf1 102 63.52 1.61 9.09E08 1.06E08*
GCR- 199 150.60 1.32 4.94E06 1.73E08*
C-fos 155 109.60 1.41 8.49E07 5.32E08*
STAT1 164 128.50 1.28 2.29E04 9.82E08**
Stat5a 62 36.70 1.69 4.37E06 6.31E07*
Relb 52 31.76 1.64 6.71E05 8.17E07*
Nf-b 34 17.17 1.98 1.31E05 2.64E05
Irf5 25 11.76 2.13 4.11E05 7.84E05
Nfya 49 28.23 1.74 1.82E05 7.96E05
Arnt 47 33.41 1.41 5.89E03 4.84E04*
Nrf2 76 59.52 1.28 9.82E03 1.01E03*
Gata-3 101 79.76 1.27 4.36E03 3.37E03*
PPAR- 61 46.11 1.32 8.78E03 3.57E03*
Sox9 54 39.29 1.37 5.73E03 1.23E02
SMAD3 152 112.20 1.35 1.56E05
a Transcription factor hubs regulated by karyopherins and identified as significantly
overconnected to data set (P	 0.05; 5% FDR). Bold highlighted transcription factor
hubs are significant for cluster C4 (see Fig. 2B) and are listed at the top. Otherwise,
transcription factors were ranked based on the P value for transcriptomics and
proteomics.
b Values for differentially expressed genes in the SARS-CoV versus SARS-ORF6 Calu3
2B4 transcriptomics data set (6,947 genes), using the Agilent platform data as
background.
c Values for differentially expressed genes and proteins in SARS-CoV versus SARS-
ORF6 Calu3 2B4 transcriptomics and proteomics data sets combined (6,947 genes,
871 proteins). *, P values were more significant than for transcriptomics alone; **, P
values were1,000-fold greater than for transcriptomics alone.
d Number of genes in the experimental data set that interacted with the transcription
factor.
e Number of genes in the experimental data set predicted to interact with the
transcription factor based on the total number of interactions on the Agilent platform
and calculated as the mean value for the hypergeometric distribution.
f Connectivity ratio (actual/expected).
g Probability for a given value of the actual value or higher (FDR-adjusted P	 0.05).
Sims et al.
3894 jvi.asm.org Journal of Virology
icSARS-CoV ORF6 is attenuated at low MOIs and in vivo.
Airway epithelial cells are major targets for SARS-CoV infection in
humans and in mice (36, 60–62). Functional characterization of
the gene sets differentially induced following icSARS-CoVORF6
and icSARS-CoV infection in either traditional human lung cell
monolayers or primary HAE cultures revealed significant induc-
tion of a number of key antiviral response genes (Fig. 8A) that may
play critical roles in the host response or in promoting efficient
virus replication. These data are consistent with the possibility
that icSARS-CoV ORF6 might be less capable of maintaining
efficient viral replication under more natural conditions (i.e., at a
lower MOI) in vitro. For example, low numbers of virus-infected
cells early in infection would afford robust antiviral host gene
expression and paracrine signaling, potentially limiting secondary
FIG 5 HAE independent confirmation studies. HAE cells were infected with wild-type or SARS-CoV ORF6 (MOI of 2) and harvested at 24, 48, and 72 h
postinfection for microarray analysis. (A) Apical wash samples were collected in triplicate at the indicated times and assessed by plaque assay in Vero E6 cells. Data
are the average titers obtained at each time point (3 samples per time point) and were plotted as PFU/ml. icSARS-CoV titers (white bars) increased through 48
h postinfection and then decreased slightly at 72 h postinfection. In contrast, replication titers for icSARS-CoVORF6 titers (gray bars) increased over the entire
course of the infection. At a slightly reduced MOI (Calu3 2B4 cell MOI of 5, versus HAE MOI of 2), icSARS-CoV ORF6 demonstrated slower growth kinetics
until later in infection in primary cells. (B) Karyopherin-mediated VDR and CREB1 transcription factor networks were significantly (P	 0.05) enriched for both
Calu3 2B4 and HAE data sets. Light gray circles, gene nodes from the Calu3 2B4 experiment; dark gray circles, gene nodes from the HAE experiment; black circles,
gene nodes that overlapped in the two experiments. (C) Comparison of gene expression in Calu3 2B4 cells (closed circles) and HAE cells (open squares)
postinfection for target gene nodes downstream, VDR and CREB1. Values are the fold change (log2) for icSARS-ORF6 versus icSARS-CoV. Calu3 2B4 cell
results represent the average expression level 
 the standard error for 3 replicates on individual arrays. HAE cell results represent the average expression for 2
replicates pooled on arrays. Scl19a2, thiamine transporter gene; Scl2a6, glucose transporter gene; Abtb5, POK family transcription factor.
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rounds of viral replication. To test this hypothesis in vitro, we
infected Calu3 2B4 cells at a low MOI (MOI of 0.01) with icSARS-
CoV or icSARS-CoV ORF6 and assessed viral titers by plaque
assays in Vero E6 cells. Peak titers for wild-type virus were de-
tected at 72 h postinfection (107 PFU/ml), while in contrast,
peak titers for icSARS-CoVORF6 (106 PFU/ml) were detected
at 96 h postinfection and titers were reduced by 1 to 2 logs at all
time points examined (Fig. 8B). These data are in contrast to pre-
viously published reports (9, 59) in which titers in Vero E6 cells
were compared, and the differences can likely be attributed to the
intact innate immune and other antiviral signaling pathways pres-
ent in the human conducting airway Calu3 2B4 cell line. Subse-
quent studies using another recombinant SARS-CoV that does
not express the ORF6 protein have also demonstrated that at a low
MOI (MOI of 0.01) in nonhuman primate kidney cells, 2- to
5-fold reductions in viral titers were detected between 6 and 24 h
postinfection (77).
To test the hypothesis that the release of the nuclear importa-
tion block mediated by the ORF6 protein might attenuate patho-
genesis, 20-week-old B6 mice (n  5 mice/time point) were in-
fected with 105 PFU of icSARS-CoV mouse-adapted virus or
icSARS-CoV ORF6 mouse-adapted virus. Weight loss was mea-
sured each day, and lungs were harvested to assess viral titers at
days 1, 2, 4, and 7 postinfection. Mice infected with icSARS-CoV
mouse-adapted virus steadily lost weight over the 7 days of infec-
tion, while in contrast, mice infected with icSARS-CoV ORF6
mouse-adapted virus lost weight through 4 days postinfection and
then began to recover and gain weight (Fig. 8C). Weight loss in
animals infected with icSARS-CoV ORF6 mouse-adapted virus
was significantly different than in mice infected with icSARS-CoV
mouse-adapted virus at days 2 to 7 postinfection (P 	 0.01 by
Student’s t test). Mock-infected mice lost no weight over the
course of the infection. Lung titers for both viruses were deter-
mined by plaque assay, and no significant differences were
measured at days 1, 2, or 7 postinfection. However, at 4 days
postinfection, titers in the mouse-adapted icSARS-CoV ORF6-
infected mice were significantly higher than mouse-adapted
icSARS-CoV-infected mice, despite their weight gain, suggesting
that viral growth kinetics were uncoupled from pathogenic out-
come (Fig. 8D) following the removal of ORF6 protein expression.
Future studies will examine the transcriptional and proteomic
profiles of the infected mouse lungs, including those of targeted
knockout mice, but these studies are beyond the scope of the cur-
rent work.
DISCUSSION
Viral antagonism of host cellular processes is well recognized as a
major mechanism for regulating viral pathogenesis and virulence.
SARS-CoV encodes several interferon antagonists that delay host
cell recognition of infection, innate immune sensing, and signal-
ing pathways, as well as interferon-stimulated gene expression;
one antagonist, ORF6 protein, does so by blocking nuclear im-
port. Many other highly pathogenic RNA viruses encode proteins
that specifically antagonize nuclear import to prevent host innate
FIG 6 Proteomic validation studies. The graphs show comparisons of individual gene RNA expression (left panels) and protein abundance (right panels) as
determined by microarray and global proteomics analysis for EDC3 and AP2M1. Values for transcripts reflect the log2-fold change in expression over mock
infection. For proteins, values represent mean protein abundance levels as measured by mass spectrometry. Error bars represent standard errors of the means
based on mean protein abundance values derived from mass spectrometry readings of three independent samples at each time point. EDC3, enhancer of
mRNA-decapping protein 3; AP3M1, adaptor-related protein complex 3. Solid gray lines, mock-infected samples; dotted lines, ORF6-infected samples; solid
black lines, wild-type-infected samples. P values were determined with the Student t test as indicated. *, P	 0.05; **, P	 0.01; ***, P	 0.001.
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immune and other critical cellular macromolecular processes to
enhance virus replication and transmission between hosts. For
example, Ebola virus VP24 binds karyopherin 1 and blocks
STAT1 nuclear import (10). The Nipah virus W protein is local-
ized to the nucleus, where it inhibits both virus- and Toll-like
receptor 3-triggered signaling in the infected cell by preventing the
phosphorylation and activation of STAT1 and subsequent down-
stream interferon-stimulated gene induction (11). Some cardio-
virus L proteins interact directly with Ran-GTPases, which are
required for the export of new nuclear mRNA (12). In these sys-
tems, observations were conducted using candidate gene markers,
limiting full recognition of the impact of viral antagonism gene
function on nuclear translocation during infection. To redress this
limitation, we used systems biology approaches that integrated
transcriptomic and proteomic data sets in primary and traditional
human lung epithelial cells to identify the impact of the ORF6
protein on host macromolecular processes. An advantage of the
SARS-CoV ORF6 protein model is that recombinant viruses lack-
ing ORF6 expression are viable and replicate efficiently in vitro
and in vivo (9, 59). Our data support the hypothesis that antago-
nists of nuclear translocation differentially target host signaling
pathways, perhaps in a tissue- and cell-specific manner, to prevent
antiviral defenses and other subcellular responses that may limit
virus replication. The data reported herein suggest that other viral
nuclear import antagonists likely antagonize multiple host tran-
scription factors and cellular processes to allow efficient virus rep-
lication, transmission, and spread. Although speculative, these an-
tagonists likely block paracrine signaling of cytoplasmic cargo
(e.g., cytokines, steroids, hormones), blocking cellular antiviral
responses during virus infection.
Viral antagonists that target nuclear translocation provide a
novel model system to study the regulated inhibition of host re-
sponse networks in the context of virus infection. One of the cur-
rent ORF6 protein functional paradigms is that it blocks nuclear
import by binding karyopherin 2 on internal membranes, se-
questering karyopherin1 and preventing karyopherin-regulated
nuclear import of key antiviral transcription factors, like STAT1.
However, STAT1 typically uses karyopherin 1 and 1 for im-
port, suggesting that the primary targets for the ORF6 protein may
actually be other key host response transcription factors and ex-
pression networks during infection. Given the unique biochemi-
cal targeting of the ORF6 protein and the fact that SARS-CoV also
encodes other proteins that antagonize innate immune signaling
(63, 64), it is not surprising that STAT1 was not positioned more
prominently as one of the key transcription factors targeted by
ORF6 protein antagonism of nuclear import in either Calu3 2B4
and HAE cultures. The global genomics-based technologies used
in this study provide an alternative approach to evaluate the role of
specific viral genes on host transcription and proteomic regula-
tory networks during infection. We recognize that karyopherin
and cargo concentrations are heavily cell type dependent, and thus
the ORF6 protein’s effect on nuclear import in other permissive
cell types might result in dramatically different hierarchical activ-
ities, leading to variations in host gene expression networks
and/or the activation of alternate transcription factors (17, 31, 65,
66). Although our initial studies focused on a recombinant virus
that lacked the entire ORF6 gene, future studies using recombi-
nant viruses lacking either the N- or C-terminal portion of the
ORF6 protein in early virus replication and nuclear import may
provide further resolution to the precise domains in the ORF6
protein that mediate these phenotypes.
In support of earlier reports (9, 17, 59), deletion of ORF6 had
minimal effects on the efficiency of virus replication in Calu3 2B4
and HAE cultures; however, these growth comparisons were per-
formed at a high MOI, which is often a less powerful barometer of
virus growth than studies with a low MOI in culture. The Calu3
2B4 and HAE culture systems represent continuous and primary
models of the human airway epithelium, a major target for early
SARS-CoV infection and replication in vivo in many species (36,
59, 67). Thus, host response outcomes in these cells likely model in
vivo responses that inform downstream innate and adaptive im-
FIG 7 Verification of CREB1 and VDR downstream target genes in icSARS-
CoV- and icSARS-CoVORF6-infected Calu3 2B4 cells. Calu3 2B4 cells were
infected with icSARS-CoV or icSARS-CoV ORF6, or mock infected, and
then harvested for ChIP at 0, 24, and 48 h postinfection. ChIP was performed
with anti-CREB (MMP19, CDKN1A), anti-VDR (MCL-1), and anti-IgG an-
tibodies (negative control) on each set of samples, and selected target genes
whose expression was regulated by either CREB1 or VDR, as identified by
microarray analysis, were verified by quantitative real-time PCR. The relative
fold enrichment levels for Mcl-1 (a), CDKN1A (b), and MMP19 (c) for ic-
SARS-CoV- or icSARS-CoV ORF6-infected Calu3 2B4 cells over the 48-h
time course are shown. The CT values were analyzed by using the standard
curve method, and each sample was normalized to the appropriate IgG sample
and to the corresponding time-matched mock infection sample. Data are the
means
 standard errors of the means for triplicate experiments. *, P	 0.05;
**, P 	 0.01 (Student’s t test). Gray bars, icSARS-CoV ORF6; black bars,
icSARS-CoV.
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mune responses during infection. At lower MOIs, more subtle
effects of the ORF6 protein have been reported on virus replica-
tion rates, especially early, but not late, in infection (59, 68). While
our data in HAE and Calu3 2B4 cultures support these earlier
findings, we designed the current experiment to include a high
MOI to reduce the impact of paracrine signaling between infected
and uninfected cells, allowing us to specifically focus on host re-
sponses during infection. Importantly, in the presence or absence
of the ORF6 protein, similar RNA expression kinetics and levels of
virus replication were noted in both Calu3 2B4 cells and HAE
cultures; thus, the virus effects on differential gene expression
likely reflected the targeted activities of the ORF6 protein directly
on virus-host regulated interactions, like nuclear translocation.
However, there were dramatic differences in the levels and rates of
FIG 8 icSARS-CoVORF6 is attenuated at low MOIs and in B6 mice. (A) Gene expression for antiviral pathways. Hierarchical clustering by Euclidean distance
of genes from two enriched biological process GO categories from Fig. 2B (cluster C6), the “defense response” (GO:0006952) and “response to virus” (GO:
0009615). A total of 71 out of 96 genes in these pathways were significantly upregulated in icSARS-CoV ORF6 compared to icSARS-CoV between 0 and 72 h
postinfection in Calu3 2B4 cells and are presented in the heat map. Values are the fold change (log2) in icSARS-CoV ORF6 versus icSARS-CoV at each time
point. Red, green, and black represent upregulated, downregulated, and unchanged genes, respectively. (B) Low-MOI Calu3 2B4 cell infection. Calu3 2B4 human
lung cells were infected with either icSARS-CoV or icSARS-CoV ORF6 (MOI of 0.01). Medium from each well was collected and analyzed by plaque assay for
viral growth kinetics in Vero E6 cells. Data are the average titer obtained at each time point (3 samples per time point) and were plotted as PFU/ml. Peak titers
for icSARS-CoV were detected at 72 h postinfection, while titers for icSARS-CoVORF6 peaked at 96 h postinfection, suggesting that the mutant was attenuated
at a low MOI over the course of the infection. Closed circles and unbroken line, icSARS-CoV; closed triangles and dashed line, icSARS-CoV ORF6. (C and D)
Weight loss (C) and titer data (D) for 20-week-old B6 mice (n 5) infected intranasally with 105 PFU of virus. Weight loss was assessed each day postinfection
through day 7, and titers were assessed at the indicated times postinfection. Mice infected with icSARS-CoV mouse-adapted virus steadily lost weight over the
course of the infection; in contrast, mice infected with the icSARS-CoV ORF6 mouse-adapted virus lost weight until day 4 postinfection, when they began to
recover from infection and to gain weight. Mock-infected mice had no appreciable weight loss at any time postinfection. Symbols in panel C: closed circles and
solid line, icSARS-CoV mouse-adapted virus; open triagles and dotted line, icSARS-CoV ORF6 mouse-adapted virus; open circles and solid line, mock
infection. No significant differences in titers were detected at days 1, 2, or 7 days postinfection. Open circles, mock infection; gray triangles, icSARS-CoVORF6
infection; filled circles, icSARS-CoV infection. Error bars indicate standard deviations from the means. Asterisks indicates a P value of	0.01 for icSARS-CoV
mouse-adapted virus versus icSARS-CoV ORF6 mouse-adapted virus. Box colors in panel D: black, icSARS-CoV; gray, icSARS-CoV ORF6.
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differential gene expression detected between the two viruses de-
spite similar replication kinetics. icSARS-CoV differential gene
expression was detectable as early as 24 h postinfection and was
higher than the levels detected for icSARS-CoV ORF6 through
36 h postinfection. At 48 h postinfection, a drastic change oc-
curred with the number of differentially expressed genes still in-
creasing for icSARS-CoV, but the number of genes detected for
icSARS-CoV ORF6 jumped to twice the level of the wild type
(Fig. 2B, ORF6 36 h 1600 versus 48 h 4750), a trend which con-
tinued through 72 h postinfection. These data tracked with levels
of detectable ORF6 protein expression (Fig. 1D) and suggest that
the changes mediated by the ORF6 protein during infection can
likely be uncoupled from replication kinetics but still modulate
pathogenesis, as seen with the weight loss recovery in the mouse
model (Fig. 8C and D).
Several of the identified transcription factors play critical roles
in lung cancer but can also mediate many acute and chronic lung
disease phenotypes. During normal lung development, CREB1
plays an important role in the differentiation of the mucin- or
mucus-producing cells (69). In contrast, studies have also dem-
onstrated that CREB1 and its associated pathways contribute to
pathological lung disease progression via inflammatory response-
mediated lung remodeling postinfection/post-lung injury (70,
71). VDR transcription factor levels are reduced in patients with
chronic obstructive pulmonary disease (COPD), and vitamin D
has been shown to be important in the onset of COPD (72, 73). In
VDR knockout mice, increased lung inflammation and emphy-
sema were noted, suggesting an important role for VDR signaling
in normal lung function and lung disease prevention or exacerba-
tion (74). The transcription factor EpasI/HIF2 is critical for re-
sponding to reduced oxygen levels in the intracellular environ-
ment (75). EpasI/HIF2 is part of the hypoxia response and was
one of the genes detected in the microarray analysis of wild-type
SARS-CoV-infected nonhuman primates, whereas in the presence
of the ORF6 protein its expression was downregulated (76, 77).
The SMAD family of transcription factors are potent inducers of
TGF-, which can activate apoptosis signaling pathways during
influenza virus infection (78). SMAD proteins as well as p53 have
also been implicated as being underexpressed in a wide variety of
cancers, including lung carcinomas (23, 79). Many viruses have
designed strategies to counter p53 signaling (80–83). Importantly,
p53 expression enhances innate immunity by enhancing IFN-de-
pendent antiviral activity via IRF-9 activation, independent of its
functions as a proapoptotic and tumor suppressor gene (80). In
some cell lines, influenza virus infection can increase p53 expres-
sion, where it is essential for the induction of cell death pheno-
types, and loss of p53 expression enhances virus growth (81).
SARS-CoV targets and infects Oct 4-expressing pluripotent lung
stem cells, which differentiate into type 1 and type 2 pneumocytes,
and is essential for repair and function of the alveoli (84). Lung
stem cells are reported targets for SARS-CoV infection, and so
blocking Oct 4 expression may well slow the rate of recovery from
lung injury by preventing differentiation of stem cells that are
essential for normal lung function and wound repair (85). All of
the transcription factor hubs identified by modeling of systems
biological approaches play critical roles in the regulation and
maintenance of lung cell homeostasis and would not have been
collectively identified in more-targeted studies.
Enrichment of karyopherin-mediated transcription factors in
icSARS-CoV ORF6 infection compared to infection with the
wild type was independently confirmed and validated from anal-
ysis of different data sets, including proteomics and ChIP-PCR
data from infected Calu3 2B4 cells and microarray data from in-
fected HAE cultures. It is reassuring that bioinformatic ap-
proaches independently validated earlier biochemical studies,
demonstrating targeted antagonism of nuclear import by using a
candidate gene approach. ChIP-PCR analysis demonstrated that
some transcription factors identified by modeling approaches
were actively bound to the promoters of specific downstream tar-
get genes (identified by microarray analysis), lending further cre-
dence to the modeling analysis (55, 86). The strength of the cur-
rent approach is that global integration of data in the context of
biological pathways or functional processes, such as transcrip-
tional factor regulation, provide a complementary interpretation
of genomic and proteomic results that is necessary for systems-
level comparisons (87). Direct comparison or integration of het-
erogeneous data sets is complicated by inherent differences
among cell types, platforms, and technologies. However, the iden-
tification of common regulatory components that induce gene or
protein signatures across model platforms can provide important
information about underlying biological processes during infec-
tion (88). The overlap in regulatory events across systems, includ-
ing comparison of infection of traditional cell lines to infection of
primary human cells, can be considered independent confirma-
tion of the mechanism of action for the ORF6 protein during
SARS-CoV infection. In this study, a range of approaches were
applied to provide a comprehensive view of karyopherin-depen-
dent nuclear importation mediated by the ORF6 protein during
SARS-CoV infection, and these approaches were not only vali-
dated across systems but also could be interpreted within the con-
text of in vitro and in vivo viral endpoints.
Removal of the ORF6 protein-mediated nuclear importation
block attenuated SARS-CoV pathogenesis in a 20-week-old B6
mouse model. There was no difference in viral growth kinetics
between icSARS-CoV and icSARS-ORF6 in human lung cells
(Calu3 2B4) at high MOIs, and in the 20-week-old mouse model
replication patterns were similar between the two viruses, with
significant titer differences at only a single time point. However,
despite similar virus loads in the lung, weight loss was significantly
reduced in mice infected with icSARS-CoV ORF6 mouse-
adapted virus compared to those infected with wild-type mouse-
adapted virus, suggesting that viral titers do not necessarily corre-
late with disease outcomes. Similar findings have been noted with
recombinant SARS-CoV bearing zoonotic Spike glycoproteins,
like HC/SZ/61/03 (77, 89). The category of genes most affected by
release of ORF6 protein nuclear importation block in vitro-regu-
lated overall gene expression, cellular rearrangement for division,
and factors required for differentiation, suggesting that the intra-
cellular environment may play a substantial role in determining
levels of viral pathogenesis and controlling the intracellular anti-
viral state.
Antagonists of nuclear import likely contribute to the viru-
lence of many highly pathogenic viruses. Importantly, some of the
transcription factors identified in cell culture models, like STAT1,
which is significantly regulated by ORF6 protein function, have
also been demonstrated to alter in vivo pathogenesis (60). In
STAT1 knockout mice, but not IFNR knockout mice, icSARS-
CoV mouse-adapted infection resulted in dysregulation of T cell
and macrophage differentiation, leading to a Th2-biased immune
response and the development of alternatively activated macro-
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phages that mediated a lethal, profibrotic environment within the
lung (90). Future studies will evaluate icSARS-CoV and icSARS-
CoVORF6 pathogenesis in p53, CREB1, EpasI, and VDR knock-
out mice. In addition to antagonizing innate immune signaling,
our data argue that antagonists of nuclear import likely target
alternative and perhaps unappreciated host signaling networks to
maximize a favorable environment for virus replication and
pathogenesis, both in vitro and in vivo.
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